BMRN: BioMarin Pharmaceutical Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14,411.88
Enterprise Value ($M) 14,752.84
Book Value ($M) 5,073.82
Book Value / Share 26.72
Price / Book 2.84
NCAV ($M) 1,186.15
NCAV / Share 6.25
Price / NCAV 12.15

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 2.74

Balance Sheet (mrq) ($M)
Current Assets 2,985.01
Assets 6,872.67
Liabilities 1,798.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,419.23
Operating Income 171.60
Net Income 167.65
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 159.26
Cash from Investing -111.24
Cash from Financing -18.73

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Dodge & Cox 7.40 -2.71
02-13 13G/A Vanguard Group Inc 9.58 3.94
02-12 13G/A Primecap Management Co/ca/ 9.78 4.74
02-09 13G Capital Research Global Investors 5.70 90.67
01-26 13G/A BlackRock Inc. 7.80 -3.06

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 55,913 383,750 14.57
2024-05-23 143,616 716,182 20.05
2024-05-22 97,414 879,801 11.07
2024-05-21 74,473 596,753 12.48
2024-05-20 168,392 705,148 23.88

(click for more detail)

Similar Companies
BIIB – Biogen Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc. BOLT – Bolt Biotherapeutics, Inc.
BPMC – Blueprint Medicines Corporation


Financial data and stock pages provided by
Fintel.io